RESULT OF RIKSBANK CERTIFICATE SALE
|Interest rate, %||0.75|
|Offered volume, SEK bn||564.0|
|Total bid amount, SEK bn||2882.1|
|Accepted volume, SEK bn||564.0|
|Number of bids||17|
|Percentage allotted, %||19.569|
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Sampo plc: Managers’ Transactions (Wahlroos/Alectoris AS)3.10.2022 08:55:00 CEST | Press release
SAMPO PLC MANAGERS’ TRANSACTIONS 3 October 2022 at 9:55 am Sampo plc: Managers’ Transactions (Wahlroos/Alectoris AS) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the Market Abuse Regulation. The transaction concerns the change of ownership in Alectoris AS. After the transaction, Wahlroos doesn’t have controlling interest in Alectoris AS. ____________________________________________ Person subject to the notification requirement Name: Björn Wahlroos Position: Member of the Board/Deputy member Issuer: Sampo plc LEI: 743700UF3RL386WIDA22 Notification type: INITIAL NOTIFICATION Reference number: 20225/5/4 ____________________________________________ Transaction date: 2022-09-27 Venue not applicable Instrument type: SHARE ISIN: FI0009003305 Nature of the transaction: GIFT, DONATION OR INHERITANCE (MADE) Transaction details (1): Volume: 570,000 Unit price: 0 N/A Aggregated transactions (1): Volume: 570,000 Volume weighted average price: 0 N/
Norsk Hydro: Status share buyback program3.10.2022 08:10:00 CEST | Press release
Please see below information about transactions made under the share buy-back program for Norsk Hydro ASA. Announcement date of the share buyback program: September 23, 2022 End date of the share buyback program: March 29, 2023 Overview of transactions: Date Aggregate daily volume (no. of shares) Volume weighted average price (NOK) Total transaction value (NOK) 26.09.2022177 00055.919 895 23827.09.2022170 00057.779 820 30528.09.2022178 00055.879 945 44729.09.2022170 00057.679 803 52630.09.2022170 00058.539 950 746Total transactions under the program:865 00057.1349 415 263 Following the above listed transactions, Norsk Hydro ASA owns a total of 17 317 403 shares, corresponding to 0.84% of Norsk Hydro ASA's share capital. Attachment: An overview of all the completed transactions under the program for the dates specified above is attached to this notification and available on www.newsweb.no. This is information that Norsk Hydro ASA is obliged to make public pursuant to the EU Market Abuse
Norsk Hydro: Status tilbakekjøp av egne aksjer3.10.2022 08:10:00 CEST | Pressemelding
Nedenfor er informasjon om transaksjoner foretatt under tilbakekjøpsprogrammet for Norsk Hydro ASA. Dato for når tilbakekjøpsprogrammet ble annonsert: 23. september 2022 Tilbakekjøpsprogrammets varighet: 29. mars 2023 Oversikt over transaksjoner: Date Aggregate daily volume (no. of shares) Volume weighted average price (NOK) Total transaction value (NOK) 26.09.2022177 00055,919 895 23827.09.2022170 00057,779 820 30528.09.2022178 00055,879 945 44729.09.2022170 00057,679 803 52630.09.2022170 00058,539 950 746Total transactions under the program:865 00057,1349 415 263 Etter gjennomføringen av overnevnte transaksjoner, eier Norsk Hydro ASA totalt 17 317 403 egne aksjer, tilsvarende 0,84% av Norsk Hydro ASAs aksjekapital. Vedlegg: En oversikt over alle gjennomførte handler under tilbakekjøpsprogrammet som er uført i overnevnte tidsperiode er vedlagt denne meldingen og tilgjengelig på www.newsweb.no. Denne opplysningen er informasjonspliktig i henhold til EUs Market Abuse Regulation og krav
Sampo plc’s share buybacks 30/09/20223.10.2022 07:30:00 CEST | Press release
SAMPO PLC STOCK EXCHANGE RELEASE 03/10/2022 at 08:30 am Sampo plc’s share buybacks 30/09/2022 On 30/09/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code)13,80843.79AQEU25,54143.80CEUX11,97643.85TQEX89,53443.80XHELTOTAL140,85943.80 *rounded to two decimals On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based on the authorization granted by Sampo's Annual General Meeting on 18 May 2022. After the disclosed transactions, the company owns in total 10,853,632 Sampo A shares representing 2.04 per cent of the total number of shares in Sampo plc. Details of
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines3.10.2022 07:30:00 CEST | Press release
First country in Latin America to sign a bilateral supply agreement thus expanding access to the monkeypox vaccine beyond the availability of vaccines through PAHOAdditional supply agreement also signed with PAHO to expand availability for its member countries COPENHAGEN, Denmark, October 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today an agreement with a Latin American country for the supply of the Company’s monkeypox vaccine. This is the Company’s first bilateral supply agreement for the vaccine in Latin America, outside the scope of the agreement entered with the Pan American Health Organization (PAHO) in August 2022, which has enabled access to the vaccine for its member countries. Through PAHO’s Revolving Fund for Access to Vaccines, the country will get access to its first monkeypox vaccines later this month and deliveries under the bilateral agreement will start in December 2022. Separately, following the initial supply agreement in August, PAHO has requested additiona